Abstract
To date, cervical cancer (cervical cancer) is the fourth most common in the female population worldwide. The World Health Organization (WHO) has provided data that 604,000 new cases of the disease were recorded in the period 2020, of which 342,000 were fatal. New combinations of cytotoxic drugs together with new molecular targets open up new prospects in the treatment of primary and recurrent cervical cancer. Based on the fact that the drug therapy of breast cancer is one of the important methods of treatment, the relevance of the study of the proposals of the regional and domestic pharmaceutical markets of medicines for the treatment of breast cancer has been determined, in order to make decisions on optimizing the assortment. The purpose of the study is a comparative analysis of the Russian and regional pharmaceutical markets of medicines for the treatment of breast cancer. The object of the study is information and reference literature on the range of medicines registered and approved for use in the Russian Federation (including the Belgorod region). The study and analysis of the assortment were carried out using the following methods: generalization, data visualization, ranking, graphical method, statistical methods.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
